Screener
Abbott ABT Accrued Manufacturing Costs
Accrued Manufacturing Costs at other companies
Other financials
Where this comes from
Reported directly by Abbott in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The source filing: Abbott’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:02 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050134
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Liabilities and Shareholders’ Investment | ||
| Current Liabilities: | ||
| Trade accounts payable | $4,794 | $4,240 |
| Salaries, wages, and commissions | 1,619 | 1,745 |
| Other accrued liabilities | 6,892 | 5,812 |
| Dividends payable | 1,093 | 1,097 |
| Income taxes payable | 411 | 569 |
| Current portion of long-term debt | 3,005 | 3,033 |
Item 1. Financial Statements and Supplementary Data
FAQ
- What is Abbott's accrued manufacturing costs?
- Abbott (ABT) reported accrued manufacturing costs of $1.62B in Q2 2026.
- How has Abbott's accrued manufacturing costs changed year-over-year?
- Abbott's accrued manufacturing costs increased by 4.5% year-over-year, from $1.55B to $1.62B.
- What is the long-term trend for Abbott's accrued manufacturing costs?
- Over 5 years (2020 to 2025), Abbott's accrued manufacturing costs has grown at a 4.3% compound annual growth rate (CAGR), from $1.42B to $1.75B.
Ask your AI about Abbott's accrued manufacturing costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude